Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons.

We also measured levels of the vesicular protein syntaxin-4, and found an approximately two-fold increase with rivastigmine treatment, although this was much smaller than the increases in PSD-95 and SNAP-25, and did not reach statistical significance.

also in 111,027 other papers